Therapeutic role of naringin in cancer: molecular pathways, synergy with other agents, and nanocarrier innovations
- 30 November 2024
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 398 (4) , 3595-3615
Abstract
Naringin, a flavanone glycoside found abundantly in citrus fruits, is well-known for its various pharmacological properties, particularly its significant anticancer effects. Research, both in vitro and in vivo, has shown that naringin is effective against several types of cancer, including liver, breast, thyroid, prostate, colon, bladder, cervical, lung, ovarian, brain, melanoma, and leukemia. Its anticancer properties are mediated through multiple mechanisms, such as apoptosis induction, inhibition of cell proliferation, cell cycle arrest, and suppression of angiogenesis, metastasis, and invasion, all while exhibiting minimal toxicity and adverse effects. Naringin’s molecular mechanisms involve the modulation of essential signaling pathways, including PI3K/Akt/mTOR, FAK/MMPs, FAK/bads, FAKp-Try397, IKKs/IB/NF-κB, JNK, ERK, β-catenin, p21CIPI/WAFI, and p38-MAPK. Additionally, it targets several signaling proteins, such as Bax, TNF-α, Zeb1, Bcl-2, caspases, VEGF, COX-2, VCAM-1, and interleukins, contributing to its wide-ranging antitumor effects. The remarkable therapeutic potential of naringin, along with its favorable safety profile, highlights its promise as a candidate for cancer treatment. This comprehensive review examines the molecular mechanisms behind naringin’s chemopreventive and anticancer effects, including its pharmacokinetics and bioavailability. Furthermore, it discusses advancements in nanocarrier technologies designed to enhance these characteristics and explores the synergistic benefits of combining naringin with other anticancer agents, focusing on improved therapeutic efficacy and drug bioavailability.Keywords
This publication has 188 references indexed in Scilit:
- Synergic Fabrication of Naringin Molecule into Polymeric Nanoparticles for the Treatment and Nursing Care of Lung Cancer TherapyJournal of Polymers and the Environment, 2021
- Protective effects of naringin against drugs and chemical toxins induced hepatotoxicity: A reviewPhytotherapy Research, 2020
- Naringin Protects Pancreatic β‐Cells Against Oxidative Stress‐Induced Apoptosis by Inhibiting Both Intrinsic and Extrinsic Pathways in Insulin‐Deficient Diabetic MiceMolecular Nutrition & Food Research, 2018
- Naringin, a natural dietary compound, prevents intestinal tumorigenesis in Apc Min/+ mouse modelJournal of Cancer Research and Clinical Oncology, 2015
- Naringin suppresses the metabolism of A375 cells by inhibiting the phosphorylation of c-SrcTumor Biology, 2015
- Naringin inhibits the invasion and migration of human glioblastoma cell via downregulation of MMP-2 and MMP-9 expression and inactivation of p38 signaling pathwayTumor Biology, 2015
- Development and evaluation of simultaneous quantification of naringin, prunin, naringenin, and limonin in citrus juiceFood Science and Biotechnology, 2015
- Naringin Attenuates the Development of Carrageenan-Induced Acute Lung Inflammation Through Inhibition of NF-κb, STAT3 and Pro-Inflammatory Mediators and Enhancement of IκBα and Anti-Inflammatory CytokinesInflammation, 2014
- Human intestinal microbial metabolism of naringinEuropean Journal of Drug Metabolism and Pharmacokinetics, 2014
- Effect of naringin pretreatment on bioavailability of verapamil in rabbitsArchives of Pharmacal Research, 2006